Evrys Bio
PrivateLast Round
VC Round
May 4, 2022
Total Funding Raised
$44.17M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Evrys Bio operates in Healthcare & Life Sciences and is based in Doylestown, Pennsylvania. Its latest recorded funding round was a VC Round in May 2022.
Evrys Bio is a biotechnology company developing host-directed, broad-spectrum small-molecule antiviral drugs that modulate human sirtuin enzymes to enhance intrinsic cellular antiviral defenses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Defense Tech
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evrys Bio Comparables
Compare Evrys Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lab11 Therapeutics | 83% | |
| Ansun BioPharma | 80% | |
| NorthLinks Bio | 79% |
For institutional investors. Book with your work email.
Evrys Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 4, 2022 | ||||
| Grant | Jul 13, 2021 | ||||
| Grant | Aug 27, 2020 | ||||
| Grant | Jul 31, 2019 | ||||
| VC Round | Dec 1, 2017 | ||||
Seed | Jun 27, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Evrys Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Benjamin Franklin Technology Partners | Series A Extension, VC Round |
| United States Department of Defense | Grant |
| Keiretsu Forum | VC Round |
| U.S. Department of Defense | Grant |
| NIH RADx | Grant |
| Pennsylvania Department of Community and Economic Development | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 71% MoM, reaching 1.5K.
- Jun 18, 2026
Monthly visitors grew 70% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Evrys Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evrys Bio's valuation, stock price, and market status.
Is Evrys Bio a public or private company?
Evrys Bio is a private company.
What is the current stock price of Evrys Bio?
Evrys Bio is a private company, so its shares have no public market price. Caplight tracks Evrys Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evrys Bio worth (valuation)?
Valuation information for Evrys Bio is not publicly available.
Can I buy Evrys Bio stock?
Evrys Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evrys Bio's last funding round?
Evrys Bio's most recent funding round was VC Round on May 4, 2022.
Who are the main investors in Evrys Bio?
Key investors in Evrys Bio include United States Department of Defense.
Will Evrys Bio IPO soon?
No public IPO plans have been announced for Evrys Bio.
How can I track Evrys Bio secondary market activity?
Caplight tracks bids, offers, and trades in Evrys Bio's shares on secondary markets.